Doxazosin Micro Pellets MUPS
Doxazosin mesylate, a quinazoline compound sold under the brand names Cardura and Carduran, is an alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia (BPH).
On February 22, 2005, the US FDA approved a sustained release form of doxazosin.
It is an alpha-1 adrenergic receptor blocker that inhibits the binding of norepinephrine (released from sympathetic nerve terminals) to the alpha-1 receptors on the membrane of vascular smooth muscle cells.
The primary effect of this inhibition is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure.
Doxazosin Micro Pellets - Multiple Unit Particle System (MUPS)
Doxazosin Micro Granules - Multiple Unit Particle System (MUPS)